Priority Review for Dersimelagon in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria by Madaline Spencer| Published on: Oct 8, 2026

Priority Review for Dersimelagon in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria by Madaline Spencer| Published on: Oct 8, 2026 Lukasz Jarzyna, Vice President of Rare Disease at LEO Pharma, discusses the Priority Review for dersimelagon in the treatment of erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). https://checkrare.com/priority-review-for-dersimelagon-in-the-treatment-of-erythropoietic-protoporphyria-and-x-linked-protoporphyria/